EUPRAXIA PHARMACEUTICALS
Eupraxia Pharmaceuticals, through research and development and collaboration of experts within the medical field (both individuals and enterprise), is discovering, developing, and plans to market innovative technologies for some of society’s most prevalent diseases. The company is advancing the development of a wide portfolio of potential drug and drug delivery system opportunities. Eupraxia intends to provide and continue to build value to its shareholders and to society through the developme... nt and marketing of its revolutionary drug and drug delivery platform combination developed in cooperation with its joint venture partner. By joining forces with a company that has a successful history of getting drugs to market Eupraxia is increasing value to shareholders by decreasing risk and making the trajectory of getting the drug to patients more linear and faster.
EUPRAXIA PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2012-01-01
Address:
Victoria, British Columbia, Canada
Country:
Canada
Website Url:
http://www.eupraxiapharma.com
Total Employee:
1+
Status:
Active
Contact:
604-558-0920
Email Addresses:
[email protected]
Total Funding:
21.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag Google Maps Google Analytics 4
Similar Organizations
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Interactive Forums, Inc.
Interactive Forums, Inc. is Creating critical insights and engagement through meaningful collaboration with healthcare experts
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Eupraxia Pharmaceuticals
Official Site Inspections
http://www.eupraxiapharma.com Semrush global rank: 8.59 M Semrush visits lastest month: 284
Unable to get host informations!!!
